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Cytomegalovirus infection of human kidney cells in vitro. To study
which structures of a kidney allograft are the main targets for cytomeg-
alovirus (CMV), human glomerular epithelial and mesangial cells, as
well as tubular epithelial and endothelial cells were isolated by steel
meshes of different pore sizes and enzymatic treatments. The various
cultured cell types were characterized by morphology and specific
antibodies. Human CMV was inoculated onto cell monolayers using
two different culture methods: conventional tissue culture and rapid
shell vial culture. To analyze whether CMV had a direct effect on the
immunologic properties of kidney parenchymal cells, MHC class I and
class II antigen expression was estimated before and after the infection.
CMV infected all kidney cells identically. All cells expressed class I
strongly after the infection, but they were class I positive prior to
infection. Class II antigens were not expressed on the cell surface either
before or after the infection. In conclusion, human kidney cells of
glomerular, tubular and vascular origin were all infected by CMV
without any difference. CMV had no significant direct effects on the
antigenic properties of the cells.
also well known from DNA sequence analyses that CMV itself
encodes molecules similar to MHC antigens [12] and that there
is a sequence homology between HLA-DR beta chain and CMV
immediate early antigens [13].
In this study, our aim was to analyze which structures of the
kidney allograft would be the targets for CMV. Secondly, we
wanted to study if the virus alone, without any additional
immunological mechanisms, could change the expression of
transplantation antigens in these structures. We investigated
the ability of CMV to infect various types of cultured normal
adult human kidney parenchymal cells in vitro. In addition, we
analyzed the expression of HLA class I and class II antigens on
the surface of cultured cells before and during CMV infection.
Methods
Isolation, culture and characterization of human kidney
parenchymal cells
Cytomegalovirus (CMV) infection is a common and often
serious complication in renal transplant patients. A variety of
clinical manifestations such as fever, leukopenia, retinitis,
pneumonia and hepatitis have been described [1]. In addition,
the virus may infect the kidney parenchyma and cause glomer-
ulopathy [2]. A multicenter seroepidemiological study demon-
strated that CMV infection impairs both patient and graft
survival in renal transplantation [31.
Association between allograft rejection and CMV infection
has been reported in several clinical series [4—6]. It has been
suggested that CMV induces rejection by increasing the expres-
sion of MHC antigens in the graft [6, 7]. MHC class II antigens
are especially important in the presentation of foreign antigens
to alloreactive T lymphocytes, and their up regulation in vivo
correlates with allograft rejection [8, 9]. The up regulation of
class II antigens on the parenchymal cells of renal allografts has
also been recorded during CMV infection [61. The CMV-
associated class II expression of kidney cells is thought to be
mediated by y-interferon, which is produced by activated T
cells. However, it has been demonstrated in vitro that viral
particles alone, without the presence of y-interferon, are able to
induce class II antigen expression on cell surfaces [10, 11]. It is
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Isolation of different cell types. Normal human adult kidneys
which could not be used for transplantation because of anom-
alies or other technical reasons, were obtained from the Divi-
sion of Transplantation, Fourth Department of Surgery, Uni-
versity of Helsinki, Finland. Human glomerular epithelial and
mesangial cells as well as tubular epithelial and endothelial cells
were isolated by steel meshes of different pore size and enzy-
matic treatment using modifications [14] of the techniques of
Burlington and Cronkite [15] and Kasten [16]. A whole kidney
was first sliced with a scalpel and forced through a steel mesh,
with 1000 mm pore size, with a syringe. The minced tissue was
diluted with serum free MEM (Minimum essential medium,
Gibco Ltd., Paisley, Scotland, UK), D-Valine was added in-
stead of L-Valine to inhibit fibroblast growth [17], supple-
mented with 50 mglml gentamycin (Gibco) and 2 mmollml
glutamine (Gibco). Tubular components were isolated by flush-
ing the tissue through a steel mesh with 250 mm pore size.
Glomerular components were collected after filtrating the su-
pernatant through 100 mm and 75 mm pore size steel meshes.
The isolated components were washed twice with serum free
MEM. After centrifugation, one part of the tubular components
was treated with 0.2 mg/ml of DNA:se (I, 600 lU/mg, Sigma
Chemical Co., St. Louis. USA) and 0.2 mglml of collagenase
(183 lU/mg, Worthington) in serum free MEM for 20 minutes at
37°C. The single cells were diluted in MEM with supplements
and 10% fetal calf serum (FCS; Sera-Lab Limited, Sussex,
England, UK) and plated in culture flasks at 37°C for two hours.
The culture medium was then discarded and new medium was
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added for touched endothelial cells. After centrifugation, one
part of the glomerular components was treated with type IV
collagenase (Sigma; 750 lU/mi in 5 ml of serum free MEM, in
37°C and 5% CO2 for 30 minutes, shaken every 5 mm). After
collagenase treatment the components were washed with MEM
containing 20% FCS and centrifuged with 200 g for five minutes.
Cell cultures. Different cells were cultured in flasks (Nun-
don, Copenhagen, Denmark) coated with collagen (Sigma; 10
mg/mi in PBS). Mesangial cells (enzyme treated giomerular
components) were cultured in MEM supplemented with genta-
mycin, glutamine and 20% FCS. Tubular and glomerular epi-
thelial cells (tubular and untreated glomerular components,
respectively) as well as tubular endothelial cells were cultured
in MEM supplemented with gentamycin, glutamine and 10%
FCS. The cell cultures were usually confluent after two weeks.
For detachment of the cells from the bottles, 5 ml versene
(Gibco; 1:5000) was added. After a 15 minute incubation at 37°C
the cells were washed through a 50 mm steel mesh to obtain
single cell suspension, washed once with MEM and cultured
again.
Characterization of different cell types. The origin of these
cells was confirmed by light microscopy and morphological
growth characteristics as well as by immunofluorescence (IF)
stainings and specific antibodies. Glomerular and tubular epi-
thelium exhibited typical epithelial morphology with phase
contrast microscopy in cultures. Cells were polygonal, and
formed a cobblestone-like monolayer when in confluence [181.
Mesangial cells were stellar, multilayered, and produced hillock
formations [19]. Endothelial cells were identified by indirect IF
staining only. To identify the various cell types in the cultures
common specific markers were used: Factor VIII for endothe-
hal cells, cytokeratin for epithelial cells and desmin for mesan-
gial cells. Indirect IF staining for Factor VIII was performed
with a rabbit anti-human Factor VIII antibody (Dakopatts,
Copenhagen, Denmark), and only endothelial cell cultures were
positive. A monoclonal anti-human desmin antibody (Lab-
systems, Helsinki, Finland) reacted only with mesangial cell
cultures, and a monoclonal anti-human cytokeratin antibody
(PKK- 1, Labsystems) reacted only with epithelial cell cultures
of glomerular and tubular origin. The specificity of the used
monoclonal antibodies has been described [20]. According to
positive reaction with specific antibodies, the purity of each cell
population was over 90%.
Infection of cultured human kidney cells with
cytomegalovirus
Human CMV strain AD 169 (a laboratory strain) and a CMV
strain isolated from human kidney transplant patient's urine
were used in the study.
Conventional tissue culture. The conventional isolation of
CMV was performed according to standard tissue culture
techniques [21]. Appropriate CMV dilutions were inoculated
onto human kidney cell monolayers. Cells were cultured in
flasks containing tissue culture medium (MEM supplemented
with glutamine, gentamycin and FCS). To detect the appear-
ance of any cytopathic effect, the cultures were examined
weekly after inoculation. In the case of a cytopathic effect the
presence of CMV in the cell culture was demonstrated using a
monoclonal antibody against CMV-specific early nuclear pro-
teins (DuPont, Billerica, California, USA), and indirect immu-
nofluorescence. To confirm the results, indirect immunoper-
oxidase staining and another monoclonal antibody against the
immediate early antigens of CMV (Biotest Pharma, Frankfurt,
Germany) were used. A modification [22] of the original immu-
noperoxidase method [23] to diagnose CMV was used.
Early-antigen immunofluorescence test. The rapid CMV shell
vial culture and an early antigen immunofluorescence test were
performed according to our own modification [24] of a method
described previously [25]. In short, the isolated kidney cells
were cultured to monolayers in MEM (supplemented with
gentamycin, glutamine and FCS) in vials on a coverslip. CMV
was inoculated onto cell monolayers by centrifugation with
3000 x g at 20°C for one hour, and the vials were incubated at
37°C with 5% CO2. The culture medium was changed once a
week. After 1 to 20 days of culture the cell monolayers were
fixed with methanol at —20°C and stained with indirect immu-
nofluorescence using a monoclonal IgG2a antibody against
early CMV nuclear protein (DuPont) to demonstrate the pres-
ence of CMV. The results were confirmed by another mono-
clonal antibody against the immediate early antigens of CMV
(Biotest Pharma) and indirect immunoperoxidase staining ac-
cording to the method described [22, 23].
Demonstration of MHC antigens
Fluorescence-activated cell sorter (FAGS) analysis. FACS
analysis was performed to estimate the expression of class I and
class II antigens on the cell surface of normal and CMV infected
cells. The monoclonal antibodies against MHC class I (HLA-
ABC, MAS 1523 c, Seralab, Sussex, England, UK) and MHC
class II (HLA-DR, OKIa1, Ortho Pharmaceutical Co, Raritan,
New Jersey, USA) were used. Cells were detached from culture
flasks with versene and spun down. Single-cell suspensions
were first exposed to a monoclonal antibody, washed twice and
then exposed to a monoclonal fluorescein isothiocyanate con-
jugated anti-mouse antibody (GAM-FITC, Coulter Immunol-
ogy, Hileah, Florida, USA), washed twice, resuspended in PBS
and evaluated by the FACS.
Immunoperoxidase staining. For further analysis of MHC
antigens in kidney cells, a three-layer immunoperoxidase tech-
nique [26] was performed for both shell vial cover slips and for
cytocentrifuged cell preparations of the conventional cultures.
The monoclonal antibodies against class I and class II antigens
were the same as used in FACS analyses. The cell preparations
were first incubated with a monoclonal mouse antibody,
washed and incubated with peroxidase-conjugated rabbit anti-
mouse antibody (Dakopatts). After washing, the cell smears
were treated with peroxidase-conjugated goat anti-rabbit anti-
body (Tago, Burhingame, California, USA) and the reaction was
revealed by AEC (3-amino-9-ethyl carbazole) solution contain-
ing hydrogen peroxide. Mayer's Hemalum was used for coun-
terstaining.
Results
CMV infection
All cell material was isolated from five adult human kidneys
and every experiment was repeated five times. Glomerular
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mesangial and epithelial cell cultures as well as tubular epithe-
hal cell and endothelial cell cultures were used in these exper-
iments after four to five passages. Cells were positively infected
with the CMV strain AD169 and with the strain from a renal
transplant patient's urine but infection efficiency was dependent
on the CMV strain (urine CMV was not as efficient as strain
AD169, data not shown).
With the early-antigen immunofluorescence test on cover-
slips the infection with different CMV strains in mesangial cell
and endothelial cell cultures was seen between days two and
three, and in tubular epithelial cell and glomerular epithelial cell
cultures between days three and four. With the conventional
tissue culture method in culture flasks the first marks (+) of
cytopathic effect (CPE) were seen after one to two weeks, but
strong (+ + +) cytopathic effect was seen only after four weeks
in all cell cultures. After CPE the positive infections were
checked with antibodies towards immediate early antigens both
with immunofluorescence and immunoperoxidase techniques
(Fig. 1, Table 1).
HLA class I and class II expression
HLA class I and class II antigens on the cell surface were
analyzed using a fluorescence activated cell sorter and mono-
clonal antibodies before and after CMV infection (Fig. 2).
Before and after CMV infection in cultured human kidney
endothelial cells, tubular epithelial as well as glomerular epithe-
hal, and mesangial cells expressed class I antigen on their
surface up to 94 to 99%. None of the tested cell types showed
a positive binding with anti-class II antibody, neither before nor
after infection with CMV. Thus, class II expression on the cell
surface could not be demonstrated in CMV-infected kidney cell
types.
While the FACS analyses demonstrated only the number of
positive cells, the immunoperoxidase analyses showed the
intensity of the staining, depending on the amount of the
antigens in the cells. The results of the immunoperoxidase
analyses are shown in Table 2. Before CMV infection, all cell
types reacted with anti-class I antibody, but the intensity of the
staining was slightly stronger after the infection. None of the
cultured kidney cell types showed a positive staining with
anti-class II antibody. When CMV infection was recorded in the
cells, endothelial cells, mesangial cells and glomerular epithehial
cells remained class II negative. Tubular epithelial cells from
two kidneys showed a slight binding with the anti-class II
antibody during CMV infection. However, this class II expres-
sion was obviously intracellular, as FACS analyses from the
same cell populations showed no class II expression on the cell
surface.
Discussion
This is the first study demonstrating that various cell types of
a normal adult human kidney can be infected by CMV in vitro.
As the cellular material was of normal kidney origin, our results
were more comparable with the clinical situation than those of
previous studies where embryonal tissues or laboratory cell
fines were used as targets. The results support the suggestion
that the renal allograft parenchyma may be infected with and
even is a reservoir of CMV. Chronic viruria after transplanta-
tion can be explained by chronic infection of the organ. As all
tested cell types of human kidney were infected, there was no
evidence that certain structures in the organ would be particu-
larly sensitive for CMV. Thus, the results demonstrate that the
glomerular structures are not particular targets for the virus,
although in the CMV associated glomerulopathy, other struc-
tures of kidney parenchyma remain intact [2].
CMV-associated glomerulopathy, which may occur in renal
allografts without any evidence of rejection, may result from
direcj infection of glomerular structures. In addition to our
investigation, previous studies on fetal tissues have shown that
CMV can replicate in fetal mesangial cells [27], as well as in
fetal glomerular epithelial cells [28] in vitro. However, also in
the same study on fetal kidney, not only glomerular compo-
nents but also tubular epithelium could be infected by CMV
[28].
It has been shown that CMV can infect endothelial cell lines
in vitro [7, 29—311. The cells used in those experiments have
usually been human umbilical venous endothelial cells
(HUVE). In the present study, it was proven that CMV also
infects endothelial cells of human kidney origin in vitro. The
infected vascular structures have been earlier demonstrated in
renal allograft biopsy and in autopsy materials only [32—341.
The relationship between MHC antigens and CMV is not yet
totally understood, but it's importance is generally admitted.
Induction of MHC class II antigen expression on renal allograft
endothelial cells and tubular epithelial cells during CMV infec-
tion has been suggested to be a link between viral infection and
rejection [6]. It has also been demonstrated that CMV increases
the expression of class I antigens on the surface of endothelial
cells [7, 31] and fibroblasts in vitro [35]. In addition, CMV can
react with MHC class I antigens [36] and bind to beta2-
microglobuhin [35]. Class I molecule is suggested to be a
receptor for CMV [36].
In the present study, none of the cultured cell types ex-
pressed class II before the infection, not even on the endothehial
cells which had been found class II positive in normal human
kidney [371. No class II antigens were demonstrated on the
surfaces of CMV infected cells either. Although tubular epithe-
hal cells showed a slight positive reaction with anti-class II
antibody, the FACS analysis demonstrated no evidence of class
II molecules on the cell surface. The positive reaction was
obviously due to intracellular class II, also demonstrated in
normal rat renal tubular epithelial cells [37]. The intensity of
class I expression was slightly increased in the infected cells,
but this finding is of minor significance, as all cells were class I
positive prior to infection.
Class II expression is known to be upregulated by yinter-
feron [38]. A mechanism has even been postulated in which
y-interferon initiates the reading of the coding sequences of the
class II genome [39]. It was postulated that in the cells normally
not expressing class II but also considered as "interferon-y-
inducible cells," both the promoter and the transcriptional
enhancer are inactive, and no gene transcription is seen.
However, after administration of y-interferon, the promoter is
activated, and the HLA-DRa gene is transcribed: the repressors
acting at the promoter can be modified through the action of
y-interferon-inducible factors [39]. Interferon-y is produced by
activated lymphocytes not only during rejection but also during
viral infections [38, 40], and it has been suggested that the
CM V-induced class II expression is mediated by 'y-interferon,
which is known to up regulate class II antigen. However, viral
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Fig. 1. Various kidney cell types. A. An endothelial cell in the culture monolayer identified by anti-factor VIII antibody and indirect
immunofluorescence (note the positive reaction in the cytoplasm). B. A CMV-positive endothelial cell demonstrated by a monoclonal antibody
against the early nuclear proteins of CMV (note the positive reaction in the nucleus). C. A glomerular epithelial cell from a conventional culture
identified by anti-cytokeratin antibody. D. A CMV-infected glomerular epithelial cell demonstrated as above. E. Tubular epithelial cells in tissue
culture before CMV infection. F. Infected tubular cells demonstrated by a monoclonal antibody against immediate early antigens of CMV and
immunoperoxidase staining (note the positive staining of nuclei and inclusion bodies).
particles alone, in the absence of y-interferon, are able to
induce class II antigen expression on some cells [10, 11]. Also
recent DNA sequence analyses have demonstrated that CMV
encodes a molecule similar to MHC class I [121, and that there
is sequence homology and immunological cross reactivity be-
tween HLA-DRI3 chain and CMV immediate early antigens
[13].
As CMV did not induce class II on kidney cells in vitro, it is
more likely that class II expression associated with CMV in
vivo is caused by lymphocyte activation and y.interferon than
958 Ustinov et al: CMV infection of human kidney cells in vitro
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Fig. 2. Fluorescence activated cell
sorter (FACS) analysis of MHC class I
and class Ii antigens on the cell
surface of normal and CMV infected
mesangial cells. A. A negative control
(background binding) before (7%) and
(B) during CMV infection (after 30 days
in culture) (4%). C. Class I positive
cells before (96%) and (D) during the
infection (98%). E. The reactivity of the
cells with anti-class II antibody
exceeded the background binding
neither before (3%) nor (F) during
infection (3%).
Table 1. Infection of human kidney cell cultures with CMV strain
AD169
Cell type ea-IF days CPE (-I- + +) days
MC 2—3 28
GEPC 3-4 28
EC 2—3 28
TEPC 3-4 30
All results are given in days. Early-antigen immunolluorescence test
(eá-IF) was done on coverslips and cytopathic effect (CPE) was
detected in culture flasks. Abbreviations are: MC, mesangial cell;
GEPC, glomerular epithelial cell; EC, endothelial cell; TEPC, tubular
epithelial cell.
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by the virus itself. On the other hand, the immunological cross
reactivity may be also involved in the mechanisms in vivo,
while the molecules coded by CMV are similar to the MHC
antigens. It is possible that the immunological response against
the MHC antigens in the kidney allograft is cross reacting with
the molecules coded by CMV and produced in the infected
cells. To understand the association between renal allograft
rejection and CMV infection thoroughly, the specificity of the
immune response should also be studied.
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